![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
SWITCHING TO DTG/3TC FIXED-DOSE COMBINATION (FDC)
IS NON-INFERIOR TO CONTINUING A TAF-BASED REGIMEN
(TBR) IN MAINTAINING VIROLOGIC SUPPRESSION
THROUGH 96 WEEKS (TANGO STUDY)
|
|
|
SWITCHING TO DTG/3TC FIXED-DOSE COMBINATION
(FDC) IS NON-INFERIOR TO CONTINUING A TAF-BASED
REGIMEN (TBR) IN MAINTAINING VIROLOGIC SUPPRESSION
THROUGH 96 WEEKS (TANGO STUDY)
![1016201](../images/101620/101620-4/1016201.gif)
![1016202](../images/101620/101620-4/1016202.gif)
![1016203](../images/101620/101620-4/1016203.gif)
![1016204](../images/101620/101620-4/1016204.gif)
![1016205](../images/101620/101620-4/1016205.gif)
![1016206](../images/101620/101620-4/1016206.gif)
![1016207](../images/101620/101620-4/1016207.gif)
![1016208](../images/101620/101620-4/1016208.gif)
References: 1. de Los Rios P, OkoliC, Punekar Y, et al. Prevalence, determinants, and impact of suboptimal adherence to HIV medication in 25 countries [published online ahead of print, 2020 Jun 25]. PrevMed. 2020;139:106182. doi:10.1016/j.ypmed.2020.1061822. 2. OkoliC, Brough G, Allan B, et al. Shared Decision Making Between Patients and Healthcare Providers and its Association with Favorable Health Outcomes Among People Living with HIV [published online ahead of print, 2020 Aug 3]. AIDS Behav. 2020;1-12. doi:10.1007/s10461-020-02973-4
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|